⚡ 20% Off Sitewide · Auto-Applied at Checkout · Free Shipping $300+ · Free GHK-Cu 50mg Over $500 ⚡
GLP3-RT 10mg research peptide vial — Triple-action GLP-1/GIP/Glucagon receptor agonist. Receptor Agonist Research category. Research-grade, third-party tested by PWR Peptides.
Receptor Agonist Research

GLP3-RT 10mg

4.9· 120+ research reviews
$70.00
per vial
1

What is GLP3-RT?

GLP3-RT 10mg triple-agonist research peptide (GLP-1/GIP/glucagon).

Research Highlights

  • Triple-receptor engagement
  • Studied across metabolic pathways
  • Lot-tested research grade
  • Compact starter vial

How It Works

GLP3-RT engages three receptors simultaneously (GLP-1, GIP, glucagon), producing a multi-axis signaling profile in research models.

Disclaimer: For research purposes only. Not for human consumption. Not FDA approved. Must be 18+ to purchase.

Certificate of Analysis — GLP3-RT 10mg

PDF

Retatrutide · Tested strength: 10 mg/vial · Lot 082026glprt10G. Results apply to this reported lot and strength.

Retatrutide Certificate of Analysis, lot 082026glprt10G, tested 08/26/2026, 10 mg/vial, purity >99%
Analyte
Retatrutide
Batch / Lot
082026glprt10G
Result
10.14 mg/vial
Label Claim
10 mg/vial
Purity
>99%
Method
HPLC
Date Tested
08/26/2026
Trust & Quality

Why Choose PWR Peptides?

  • Research Use Only

    Every product is intended strictly for laboratory and research applications.

  • Secure Packaging

    Discreet, temperature-conscious packaging protects each vial in transit.

  • Fast Shipping

    Most orders leave our US fulfillment center within 24 business hours.

  • Responsive Support

    Real humans reply to research and order questions, usually same-day.

  • Batch Tracking

    Batch identifiers are recorded for applicable products for full traceability.

Documentation is maintained for applicable product batches. Additional information may be available upon request when applicable. Contact support for inquiries.

Related Products

FAQ

Total
$70.00
PWR Peptides
Choose your background

Tap a color to enter the site